Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease
- 1 November 2005
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 15 (s3) , 282-290
- https://doi.org/10.1111/j.1525-1438.2005.00433.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The Human Leukocyte Antigen Region and Colorectal Cancer RiskDiseases of the Colon & Rectum, 2005
- Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesisInternational Journal of Cancer, 2002
- AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTEREuropean Journal of Immunogenetics, 1997
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- Lack of interleukin‐2 (IL‐2) expression and selective expression of IL‐10 mRNA in human renal cell carcinomaInternational Journal of Cancer, 1995
- Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor‐infiltrating lymphocytesInternational Journal of Cancer, 1995
- Expression of Fas Antigen on Keratinocytes In Vivo and Induction of Apoptosis in Cultured KeratinocytesJournal of Investigative Dermatology, 1994
- Interleukin‐10 production by human carcinoma cell lines and its relationship to interleukin‐6 expressionInternational Journal of Cancer, 1993
- Interleukin-10Annual Review of Immunology, 1993
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991